A Population‐Based Study of Infectious Diseases Mortality Risk in Patients With Hematologic Malignancies 2000–2020
Cancer Medicine · 2025
DOI: 10.1002/cam4.70850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Wenshuai Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan, China. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Communicable Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with hematologic malignancies are at high risk of dying from infectious diseases. However, little attention has been paid to infectious diseases mortality (IDM) in these patients. The aim of our study is to determine the incidence and trends of IDM in patients with hematologic malignancies, identify risk factors associated with IDM, and compare the risk of IDM in patients with the general United States population.
Methods
The data of patients with hematologic malignancies between 2000 and 2020 was retrieved from the Surveillance, Epidemiology, and End Results program. Standardized mortality ratios (SMRs) and IDM rates were calculated. A competing risk model was performed to identify potential risk factors of IDM.
Results
Among 700,678 patients, 15,028 IDM were identified with an IDM rate of 401.31/100,000 person‐years. Compared with the general population, the SMR of IDM was 3.34, and the elevated risk of IDM ran through the follow‐up period. For all cancer subtypes, the IDM rates were highest in the first 2 months after diagnosis and gradually declined thereafter. For all patients, the early period of diagnosis, older age, male, non‐Hispanic black, single or divorced/separated/widowed status, no chemotherapy, and no radiation were risk factors for IDM. For patients with Hodgkin lymphoma or non‐Hodgkin lymphoma, advanced stage was also a risk factor for IDM.
Conclusion
Given the high risk of IDM in patients with hematologic malignancies, it is extremely important to identify patients at high risk of IDM and provide timely intervention to prevent early death from infections and improve prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan, China.
- Senior Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
ORCID-Profile: Wenshuai Zheng, Xiaoning Gao
Zitieren
APA
Zheng, W., Wang, S., Peng, B., & Gao, X. (2025). A Population‐Based Study of Infectious Diseases Mortality Risk in Patients With Hematologic Malignancies 2000–2020. Cancer Medicine. https://doi.org/10.1002/cam4.70850
Vancouver
Zheng W, Wang S, Peng B, Gao X. A Population‐Based Study of Infectious Diseases Mortality Risk in Patients With Hematologic Malignancies 2000–2020. Cancer Medicine. 2025. doi:10.1002/cam4.70850
BibTeX
@article{Zheng2025,
author = {Zheng, Wenshuai and Wang, Shenyu and Peng, Bo and Gao, Xiaoning},
title = {A Population‐Based Study of Infectious Diseases Mortality Risk in Patients With Hematologic Malignancies 2000–2020},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70850}
}
EUVIMED